CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

10 hedge funds and large institutions have $25.8M invested in Celyad Oncology SA American Depositary Shares in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
RIM
1
RS Investment Management
California
$16.6M +$20.7K +380 +0.1%
CAM
2
Cormorant Asset Management
Massachusetts
$4.09M
DCM
3
DAFNA Capital Management
California
$1.64M
Bank of America
4
Bank of America
North Carolina
$1.09M
VIA
5
Vident Investment Advisory
Georgia
$829K +$829K +15,182 New
Zurich Cantonal Bank
6
Zurich Cantonal Bank
Switzerland
$581K +$23K +422 +4%
OMC
7
Old Mission Capital
Illinois
$534K +$534K +9,776 New
Morgan Stanley
8
Morgan Stanley
New York
$258K +$75.4K +1,381 +41%
UBS Group
9
UBS Group
Switzerland
$165K +$18.1K +331 +12%
HM
10
HealthCor Management
New York
-$3.65M -87,181 Closed
PA
11
Perceptive Advisors
New York
-$3.14M -75,000 Closed